Siloton is on a mission to leverage the latest advancements in integrated photonics to improve the global population’s health

 
 
 
Siloton home optical coherence tomography eye scanner for age-related macular degeneration and diabetic macular oedema

What do we do?

AMD impacts 1 in 4 of those over the age of 60. These patients are currently being treated days or weeks too late, causing avoidable loss of vision. Siloton is developing a remote monitoring service that will enable patients to be treated as soon as required.

Learn more

 
 
 
 

“Siloton is developing a type of remote monitoring service that would be a game-changer for improving care for AMD patients, and preventing sight loss”

Winfried Amoaku

Consultant Ophthalmologist & Associate Professor, the University of Nottingham.

 
Slide9.png
 

Our progress would Not have been possible without the support of our valued partners